SEATTLE, Dec. 17, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today that it has been selected as a winner in the sixth annual Fierce Innovation Awards: Life Sciences Edition, an awards program from the leading industry publisher of FierceBiotech and FiercePharma aimed at identifying and showcasing outstanding innovations driving improvements and transformation in the digital health, biotech, and pharma industries. BardyDx earned top honors for the Carnation Ambulatory Monitor (“CAM™”), the world’s first P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device. Read More
In April, HEP III made an investment in Intraprise Health (https://intraprisehealth.com/), a Certified HITRUST Assessor and award-winning eHealth technology firm. The company provides health information security products and services to assess, remediate, and monitor customers’ cyber security risk, regulatory compliance programs, organizational resilience, and third-parties’ security posture.
Todd Fisher, Founder and CEO of Intraprise Health, has spent over 25 years as a health information technology innovator, focusing most heavily on the sensitive information needs and relationship between providers, patients, and communities. He is the former CEO of MobileMD, a HEP I portfolio company that was sold to Siemens Healthcare (now Cerner) in 2011. Read More
Collaboration between Wildflower, Care1st (Blue Shield of California Promise Health Plan effective 1/1/19), an affiliate of Blue Shield, and the California Health Care Foundation extends critical health knowledge to Medi-Cal beneficiaries
Mothers and babies across California are about to experience a new level of support thanks to a unique collaboration that puts vital health education resources right at their fingertips. The initiative between Wildflower Health, Care1st Health Plan (Blue Shield of California Promise Health Plan effective 1/1/19), an affiliate of Blue Shield of California, and the California Health Care Foundation (CHCF) is designed to ensure that Medi-Cal families have access to the information they need to make important decisions about their health care. Read More
BLOOMFIELD, Conn. – Global health service company Cigna launched the new Cigna Healthy Pregnancy app to better connect individual customers to Cigna’s suite of health benefits including the Cigna Healthy Pregnancies, Healthy Babies maternity health engagement program. The Cigna Healthy Pregnancies, Healthy Babies program has shown to positively impact health outcomes for pregnant women and their babies. Read More
SEATTLE, Sept. 26, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s first P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced it was selected as one of six winners of the “Make Your Medical Device Pitch for Kids!” Competition hosted by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System.
Eleven finalists from a field of 45 worldwide submissions were selected to present their products this past weekend at the Sixth Annual Pediatric Device Innovation Symposium. A distinguished judging panel of industry experts awarded BardyDx a $25,000 prize based on the CAM patch’s pediatric-friendly design, innovative P-wave centric technology, and potential to address significant unmet needs in pediatric healthcare. Read More
Wildflower Health, a leading mobile health software company, today announced it has launched enhanced capabilities to support new parents during the critical first 1,000 days. Building on the strength of its maternity programming, Wildflower’s Family Health platform can now support parents as they manage the health needs of their newborns and their entire family during early childhood.
Countless research studies have documented the importance of the first 1,000 days, from conception until a child’s second birthday. Without a strong support system, issues stemming from malnutrition and undetected developmental delays can have a negative and irreversible impact that lasts a lifetime. Read More
AxiaMed, an innovative healthcare payments technology company, announced today that it has raised $12.4 million in funding to accelerate its growth in the burgeoning market for secure, flexible patient payments. Health Enterprise Partners (HEP) led the round with participation by a number of AxiaMed’s existing investors, including Nashville Capital Network. Read More
The In-Demand devices intend to improve the patient experience.
“So we are rolling out this week into the Magic Valley, Wood River and Jerome our new video interpreting device that will help us support our patient population that is limited in English proficient, or the deaf and hard of hearing,” said Michelle Ross, the director of patient services. Read More
SEATTLE, July 16, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s first P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced today it has raised additional growth capital from its existing equity investors, including SV Health Investors (“SVHI”), Health Enterprise Partners, and Ascension Ventures. The growth capital will be used to expand BardyDx’s sales force and monitoring services, advance research and development programs, and accelerate development of artificial intelligence diagnostic capabilities. Read More